IBIO (IBIO)
$3.26
0.04 (1.07%)
IBIO Stock Quote Delayed 30 Minutes
9 Top Robinhood Stocks You May Want to Avoid Here
Many Robinhood stocks have soared as money flooded in at March lows. But the platform's investors have these nine names wrong.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
$3.80
Market Cap
31.85M
PE Ratio
-0.31
EPS
-10.5977
Volume (Avg. Vol.)
788,389
Day's Range
$3.06 - $3.80
52-Week Range
$1.50 - $6.89
Dividend & Yield
N/A (N/A)
IBIO Stock Predictions, Articles, and IBIO News
iBio Stock Has Tripled in a Few Weeks. Here’s What’s Next
iBio stock has been surging over the past few trading sessions, as investors continue to bet on its success. Can it continue higher?
It’s Too Late to Chase Coronavirus Play iBio Stock
That being said, it's too risky to go short as well. The party may soon be over for coroanvirus stocks. But you never know when exactly the music is going to stop. In other words, don't be a hero by trying to call a top. So, what's the play? Stay on the sidelines with IBIO stock.
IBIO Stock Remains a Spec Play on a Potential Vaccine
Investors in iBio (NYSEAMERICAN:IBIO) remain curious about hedging potential bets on the shares. So, how should investors looking to make a speculative play on iBio…
Is IBIO Stock Even A Bet Worth Taking?
A recent study out of the UK suggests that immunity following infection might wear off just a few months after infection. That should throw a wet blanket on any remaining hopes of a V-shaped economic recovery. But it’s potentially great news for iBio stock.
iBio Stock Is Worth the Gamble in the Covid-19 Vaccine Race
In the race towards a Covid-19 vaccine, iBio stock offers upside potential to investors who are willing to take a calculated risk.
Bulls in Charge of iBio Stock Since March
iBio stock success depends on a binary event, so the thesis is very simple. Buy it now on good faith or watch it from the sidelines.
A Safer Way to Play IBio Stock Could Spread Like the Coronavirus
The reason I mentioned iBio’s addition to the indexes is that it shows how little investors really know about what’s happening behind the scenes at iBio’s vaccine central. There's a dearth of information available.
3 Reasons to Invest in, Not Trade iBio
During the initial strike of the novel coronavirus, IBIO stock was a huge gamble. But with the stakes raised, the underlying biotech firm could turn out to be instrumental.
Big Catalysts Are Just Around the Corner for iBio Stock
Asset prices don't go up in a straight line, even if the company shows promise. Use the dip in IBIO stock now to get in at a favorable price.
The Curtain Is Coming Down on IBIO
It appears iBio may have to settle for an assist in the race for a Covid-19 vaccine, but that gives investors little reason to buy IBIO stock.
IBM Partnership and Rising Covid-19 Cases Are Lifting iBio Stock
Fears of a second coronavirus wave have Covid-19 focused biotech stocks surging again. So where does IBIO stock fit into the mix?
Right Now, iBio Stock Is Even More Risky Than You Might Have Thought
Buying a stock because it could be part of the solution to coronavirus is a risky way to play an already volatile market. IBIO stock's weak financials make it all the more dependent on coronavirus drugs to deliver.
iBio Is in a Healthy Position With Covid-19 Vaccine Push
iBio stock is still a buy but it needs to land contracts with some major vaccine developers as we get closer to a Covid-19 vaccine
3 Pros, 3 Cons For Buying iBio Stock Right Now
IBIO stock has drawn a good deal of interest of late. It's a speculative play with the potential to reward optimistic investors handsomely.
Coronavirus Hype Is Boosting iBio Shares to Unrealistic Levels
The enthusiasm surrounding iBio stock is warranted since the company is yet to deliver a viable, commercially successful vaccine.
FastPharming Tech Makes iBio Stock a Buy
Unlike other vaccine stocks, iBio has the tech it needs to scale up manufacturing of its candidate. That makes IBIO stock a buy here.
More Suspect PR and Now One More Reason to Walk Away From IBIO Stock
For investors in search of a novel coronavirus play, IBIO’s puny capitalization and continued one-trick pony press releases are fair warning and, increasingly, so is the price chart.
Why iBio Stock Could Triple on Successful Vaccine Trials
The price of iBio stock could double, if not triple in value on successful trials, and on the potential for FDA approval in the near term.
